Neurológia pre prax 3/2020
Multiple sclerosis (MS) is autoimmune disorder affecting the central nervous system
Currently, we have a fairly wide range of disease – modifying drugs (DMD) with different mechanisms of action and different efficiencies. To obtain the most efficient therapeutic results we need to choose an individual approach for appropriate therapy. It is also very important to keep in mind the risk of this therapy for appropriate patient. The continual clinical and laboratory monitoring of the patients is unavoidable.
Keywords: multiple sclerosis, disease modifying therapy (DMT)
